EDEN

Evaxion, a frontrunner in AI-driven biotechnology, is set to participate in this year’s ESMO Immuno-Oncology Congress, where it will present its customizable cancer vaccine development system, fueled by its own AI technology. This innovative system utilizes AI to analyze patient data, focusing on a specific target: ERV tumor antigens that exhibit a shared pattern among numerous […]